As part of its efforts to help create a more responsible marketplace for vapor products, Bidi Vapor submitted a Premarket Tobacco Applications (PMTA) to the U.S. Food and Drug Administration (FDA) back in September 2020. This process allows vapor companies to legally sell and market their products in the U.S. following a review and authorization by the FDA. Bidi Vapor’s applications included details about the ingredients found in its e-liquids, device components and manufacturing processes, as well as scientific research relating to consumer use. Bidi Vapor’s PMTA was over 285,000 pages upon final submission.
For all the latest news from Bidi Vapor, visit bidivapor.com.
